Takeda shareholders approve $62 billion bid for Shire. Despite a campaign by some shareholders to block the deal, the Japanese pharmaceutical giant's acquisition of the U.K. drugmaker will help it to gain a greater foothold in more lucrative markets.
What's wrong with your Venmo account? The Journal's Katherine Bindley writes that the payment app does well on what it's supposed to do: let friends exchange money quickly and easily. But you might be sharing more than you think. Here’s how to tighten up your privacy settings.